Stanford Comprehensive Epilepsy Program

Overview: Stanford is a highest-level epilepsy center, offering new methods of treating and diagnosing epilepsy. The mission is to deliver the best available care and beyond, while pushing the forefronts of epilepsy care beyond the ordinary.

The core of the program is a large outpatient epilepsy outpatient clinic with approximately 1300 visits in 2022. The beautiful Stanford new hospital opened in 2020, including a 10-bed dedicated epilepsy monitoring unit (EMU). In 2022, 212 patients were admitted to the unit, when the census was still recovering from the COVID epidemic.  Average length of stay was 4 days. A total of 1.464 long-term video-EEGs were interpreted, including IICU,  Neurology service, ambulatory EEGs, high-density dipole EEGs and routine outpatient EEGs.

Dr. Parvizi leads the neurological side of the epilepsy surgery and refractory epilepsy program. Stanford is a Level IV (highest level) program in the ratings of the National Association of Epilepsy Centers. In 2022, Stanford performed 81 epilepsy surgeries, including 9  RNS implants, 7 DBS implants, 5 new VNS implants, 17 resections and laser ablations and several other procedures.

Strategic Goal: To serve as a global referral center for refractory epilepsy that does not respond to anti-seizure medications.

  •  Advanced surgery techniques
  • Neuromodulation
  • Diagnosis and treatment of non-epileptic seizures

Adult Epilepsy Patient Care

Stanford Health Care’s nationally-recognized Comprehensive Epilepsy Program provides comprehensive care and treatment for epilepsy.

Pediatric Epilepsy Patient Care

The Pediatric Epilepsy Center at Lucile Packard Children’s Hospital Stanford